A scientific claim decoder for separating human outcomes from biomarkers, animal evidence, mechanisms, and marketing around GLP-1s, peptides, and longevity therapies.
Eight source-backed questions for checking an online GLP-1 provider’s clinical accountability, medication category, pharmacy, follow-up, claims, price, and commercial influence.
A plain-language guide to affiliate, paid-placement, medication-category, price, and evidence disclosures on GLP-1 pages.
A practical evidence matrix for checking GLP-1 claims by exact product, approval, population, endpoint, trial design, care accountability, and commercial incentive.
A source-backed verification hub for decoding GLP-1 claims, checking telehealth transparency, understanding compounded-product risks, and finding accountable care.
A sweeping review of 350 studies says the protein supplement boom may be overselling something most sedentary adults do not actually need, and that eating less of it could activate…
The FDA and CMS are testing a new bridge from AI-enabled chronic-care technology to Medicare payment, real-world evidence, and measurable patient outcomes. The promise is real. The proof is not…
A randomized controlled trial from the University of Nottingham has delivered a striking result: a simple, daily prebiotic fiber supplement reduced knee osteoarthritis pain in six weeks, rivaled the effects…
The most consistent finding in nutrition science is also the least marketable: variety beats optimization. Researchers running the American Gut Project, one of the largest citizen science microbiome studies ever…
A gut bacterial metabolite called imidazole propionate has gone from obscure molecule to validated driver of insulin resistance, type 2 diabetes, heart failure, and atherosclerosis. Inside the University of Gothenburg…
Zach RobertsSign up for personalized wellness coaching and the Daily Discovery Newsletter.